AR104807A1 - Compuestos de 2,5-dialquil-4-h/halo/éter-fenol - Google Patents

Compuestos de 2,5-dialquil-4-h/halo/éter-fenol

Info

Publication number
AR104807A1
AR104807A1 ARP160101555A ARP160101555A AR104807A1 AR 104807 A1 AR104807 A1 AR 104807A1 AR P160101555 A ARP160101555 A AR P160101555A AR P160101555 A ARP160101555 A AR P160101555A AR 104807 A1 AR104807 A1 AR 104807A1
Authority
AR
Argentina
Prior art keywords
phenol
methyl
bromo
isopropyl
ethyl
Prior art date
Application number
ARP160101555A
Other languages
English (en)
Inventor
Martinez Eduardo
Talley John
Kumar Mishra Rajesh
Baker Max
Original Assignee
Tansna Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tansna Therapeutics Inc filed Critical Tansna Therapeutics Inc
Publication of AR104807A1 publication Critical patent/AR104807A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/04—Phenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/06—Alkylated phenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
    • C07C39/27—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms all halogen atoms being bound to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
    • C07C39/27—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms all halogen atoms being bound to ring carbon atoms
    • C07C39/28—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms all halogen atoms being bound to ring carbon atoms the halogen being one chlorine atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/42—Halogenated derivatives containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente divulgación provee compuestos fenólicos útiles en el tratamiento de estados clínicos neurológicos como por ejemplo convulsiones y temblores. Reivindicación 1: Un compuesto caracterizado porque se selecciona entre el grupo que consiste en: 4-bromo-5-etil-2-metil-fenol; 4-fluoro-5-isopropil-2-metil-fenol; 4-bromo-5-tert-butil-2-metil-fenol; 4-bromo-5-ciclopropil-2-metil-fenol; 4-bromo-2-etil-5-isopropil-fenol; 4-cloro-2-etil-5-isopropil-fenol; 2-etil-4-fluoro-5-isopropilo fenol; 4-bromo-5-isopropil-2-propil-fenol, 5-isopropil-2-propil-fenol; y 4-bromo-2,5-isopropil-fenol. Reivindicación 2: Un compuesto caracterizado porque se selecciona entre el grupo que consiste en: 4-bromo-2-metil-5-(2,2,2-trifluoro-1-metil-etil)-fenol; 4-bromo-5-(2-fluoro-1-metil-etil)-2-metil-fenol; 4-bromo-2-metil-5-(2,2,2-trifluoro-1-trifluorometil-etil)-fenol; 4-bromo-2-trifluorometil-5-(2,2,2-trifluoro-1-metil-etil)-fenol; 4-bromo-2-ciclopropil-5-isopropil-fenol; 4-bromo-2,5-diciclopropil-fenol; 5-isopropil-2-metil-4-trifluorometoxi-fenol; 2-ciclopropil-5-isopropil-4-trifluorometoxi-fenol; 5-ciclopropil-2-metil-4-trifluorometoxi-fenol; 2,5-diciclopropil-4-trifluorometoxi-fenol; 4-tert-butoxi-5-ciclopropil-2-metil-fenol; 4-tert-butoxi-2-ciclopropil-5-metil-fenol; 4-tert-butoxi-2,5-diciclopropil-fenol; 4-isopropoxi-5-isopropil-2-metil-fenol; 4-bromo-5-isopropil-2-trifluorometil-fenol; 4-bromo-5-(2-fluoro-1-metil-etil)-2-metil-fenol; y 4-tert-butoxi-5- isopropil-2-metil-fenol.
ARP160101555A 2015-05-28 2016-05-27 Compuestos de 2,5-dialquil-4-h/halo/éter-fenol AR104807A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/032876 WO2016190871A1 (en) 2015-05-28 2015-05-28 2,5-dialkyl-4-h/halo/ether-phenol compounds

Publications (1)

Publication Number Publication Date
AR104807A1 true AR104807A1 (es) 2017-08-16

Family

ID=57393569

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101555A AR104807A1 (es) 2015-05-28 2016-05-27 Compuestos de 2,5-dialquil-4-h/halo/éter-fenol

Country Status (3)

Country Link
AR (1) AR104807A1 (es)
TW (1) TW201717922A (es)
WO (1) WO2016190871A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106810513A (zh) * 2017-01-10 2017-06-09 湖南华腾制药有限公司 一种哌嗪衍生物的制备方法
CN112812126B (zh) * 2021-01-28 2022-04-05 天津全和诚科技有限责任公司 一种双通道荧光探针的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121309A (en) * 1996-03-18 2000-09-19 Eisai Co., Ltd. Fused-ring carboxylic acid derivatives
US7312250B2 (en) * 2002-03-12 2007-12-25 University Of Iowa Research Foundation Fluorine-substituted alkyl phenol compounds and their uses
EP1951260A4 (en) * 2005-10-21 2009-11-11 Bezwada Biomedical Llc FUNCTIONALIZED PHENOLIC COMPOUNDS AND POURABLE ARTICLES THEREOF

Also Published As

Publication number Publication date
TW201717922A (zh) 2017-06-01
WO2016190871A1 (en) 2016-12-01

Similar Documents

Publication Publication Date Title
SV2018005709A (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
CL2018000429A1 (es) Moduladores de la expresión de kras
UY36419A (es) Composiciones farmacéuticas que contienen anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
AR111986A1 (es) Suplemento y composición de pienso animal
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
GT201300083A (es) Composiciones fungicidas
ECSP10010007A (es) Tratamiento con ligandos alpha-7-selectivos
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
IN2015DN00438A (es)
CL2015002571A1 (es) Composiciones y métodos para le diagnostico y tratamiento del cáncer hepático.
BR112016026544A2 (pt) métodos para inibir a necroptose
DOP2017000120A (es) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
MA34598B1 (fr) Procédés et compositions pour traiter le cancer du poumon
BR112013012795B8 (pt) processo de tratamento de produtos vegetais e composição
CL2018003655A1 (es) Procedimiento de fabricación de briquetas que contienen un compuesto calcio-magnesiano y un compuesto a base de hierro, y briquetas así obtenidas.
MX2018015410A (es) Esteres de oxaborol y sus usos.
CL2011003211A1 (es) Mezclas fungicidas que comprenden azolilmetiloxiranos y otro compuesto; compuestos derivados de azolilmetiloxirano; composicion agroquimica; y procedimiento para el combate de hongos fitopatogenos.
IN2014DN07224A (es)
CL2012001031A1 (es) Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros.
PH12019501224A1 (en) Compositions for treatment of polycystic kidney disease
MX2013014488A (es) Metodos y composiciones para tratar el cancer cerebral.
AR104807A1 (es) Compuestos de 2,5-dialquil-4-h/halo/éter-fenol
IN2014DN07220A (es)
EP4324477A3 (en) Oxabicycloheptanes for modulation of immune response

Legal Events

Date Code Title Description
FB Suspension of granting procedure